Protein Expression Market Size, Share & Trends Report

Protein Expression Market (2025 - 2030) Size, Share & Trends Analysis Report By Expression Systems (Prokaryotic, Mammalian cell), By Product (Reagents, Competent cells, Instruments), By Application, By End Use, By Region, And Segment Forecasts

Market Segmentation

Protein Expression Expression Systems Outlook (Revenue, USD Million, 2018 - 2030)
- Prokaryotic
- Mammalian cell
- Insect cell
- Yeast
- Others
Protein Expression Product Outlook (Revenue, USD Million, 2018 - 2030)
- Reagents
- Competent cells
- Expression vectors
- Services
- Instruments
Protein Expression Application Outlook (Revenue, USD Million, 2018 - 2030)
- Therapeutic
- Industrial
- Research
Protein Expression End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Pharmaceutical and biotechnological companies
- Academic research
- Contract research organizations
- Others
Protein Expression Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Expression Systems Outlook (Revenue, USD Million, 2018 - 2030)
    - Prokaryotic
    - Mammalian cell
    - Insect cell
    - Yeast
    - Others
  - North America Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Reagents
    - Competent cells
    - Expression vectors
    - Services
    - Instruments
  - North America Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Therapeutic
    - Industrial
    - Research
  - North America End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Pharmaceutical and biotechnological companies
    - Academic research
    - Contract research organizations
    - Others
  - U.S
    - U.S. Expression Systems Outlook (Revenue, USD Million, 2018 - 2030)
      - Prokaryotic
      - Mammalian cell
      - Insect cell
      - Yeast
      - Others
    - U.S. Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents
      - Competent cells
      - Expression vectors
      - Services
      - Instruments
    - U.S. Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic
      - Industrial
      - Research
    - U.S. End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnological companies
      - Academic research
      - Contract research organizations
      - Others
  - Canada
    - Canada Expression Systems Outlook (Revenue, USD Million, 2018 - 2030)
      - Prokaryotic
      - Mammalian cell
      - Insect cell
      - Yeast
      - Others
    - Canada Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents
      - Competent cells
      - Expression vectors
      - Services
      - Instruments
    - Canada Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic
      - Industrial
      - Research
    - Canada End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnological companies
      - Academic research
      - Contract research organizations
      - Others
  - Mexico
    - Mexico Expression Systems Outlook (Revenue, USD Million, 2018 - 2030)
      - Prokaryotic
      - Mammalian cell
      - Insect cell
      - Yeast
      - Others
    - Mexico Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents
      - Competent cells
      - Expression vectors
      - Services
      - Instruments
    - Mexico Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic
      - Industrial
      - Research
    - Mexico End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnological companies
      - Academic research
      - Contract research organizations
      - Others
- Europe
  - Europe Expression Systems Outlook (Revenue, USD Million, 2018 - 2030)
    - Prokaryotic
    - Mammalian cell
    - Insect cell
    - Yeast
    - Others
  - Europe Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Reagents
    - Competent cells
    - Expression vectors
    - Services
    - Instruments
  - Europe Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Therapeutic
    - Industrial
    - Research
  - Europe End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Pharmaceutical and biotechnological companies
    - Academic research
    - Contract research organizations
    - Others
  - UK
    - UK Expression Systems Outlook (Revenue, USD Million, 2018 - 2030)
      - Prokaryotic
      - Mammalian cell
      - Insect cell
      - Yeast
      - Others
    - UK Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents
      - Competent cells
      - Expression vectors
      - Services
      - Instruments
    - U.S. Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic
      - Industrial
      - Research
    - UK End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnological companies
      - Academic research
      - Contract research organizations
      - Others
  - Germany
    - Germany Expression Systems Outlook (Revenue, USD Million, 2018 - 2030)
      - Prokaryotic
      - Mammalian cell
      - Insect cell
      - Yeast
      - Others
    - Germany Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents
      - Competent cells
      - Expression vectors
      - Services
      - Instruments
    - Germany Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic
      - Industrial
      - Research
    - Germany End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnological companies
      - Academic research
      - Contract research organizations
      - Others
  - France
    - France Expression Systems Outlook (Revenue, USD Million, 2018 - 2030)
      - Prokaryotic
      - Mammalian cell
      - Insect cell
      - Yeast
      - Others
    - France Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents
      - Competent cells
      - Expression vectors
      - Services
      - Instruments
    - France Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic
      - Industrial
      - Research
    - France End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnological companies
      - Academic research
      - Contract research organizations
      - Others
  - Italy
    - Italy Expression Systems Outlook (Revenue, USD Million, 2018 - 2030)
      - Prokaryotic
      - Mammalian cell
      - Insect cell
      - Yeast
      - Others
    - Italy Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents
      - Competent cells
      - Expression vectors
      - Services
      - Instruments
    - Italy Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic
      - Industrial
      - Research
    - Italy End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnological companies
      - Academic research
      - Contract research organizations
      - Others
  - Spain
    - Spain Expression Systems Outlook (Revenue, USD Million, 2018 - 2030)
      - Prokaryotic
      - Mammalian cell
      - Insect cell
      - Yeast
      - Others
    - Spain Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents
      - Competent cells
      - Expression vectors
      - Services
      - Instruments
    - Spain Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic
      - Industrial
      - Research
    - Spain End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnological companies
      - Academic research
      - Contract research organizations
      - Others
  - Denmark
    - Denmark Expression Systems Outlook (Revenue, USD Million, 2018 - 2030)
      - Prokaryotic
      - Mammalian cell
      - Insect cell
      - Yeast
      - Others
    - Denmark Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents
      - Competent cells
      - Expression vectors
      - Services
      - Instruments
    - Denmark Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic
      - Industrial
      - Research
    - Denmark End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnological companies
      - Academic research
      - Contract research organizations
      - Others
  - Sweden
    - Sweden Expression Systems Outlook (Revenue, USD Million, 2018 - 2030)
      - Prokaryotic
      - Mammalian cell
      - Insect cell
      - Yeast
      - Others
    - Sweden Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents
      - Competent cells
      - Expression vectors
      - Services
      - Instruments
    - Sweden Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic
      - Industrial
      - Research
    - Sweden End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnological companies
      - Academic research
      - Contract research organizations
      - Others
  - Norway
    - Norway Expression Systems Outlook (Revenue, USD Million, 2018 - 2030)
      - Prokaryotic
      - Mammalian cell
      - Insect cell
      - Yeast
      - Others
    - Norway Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents
      - Competent cells
      - Expression vectors
      - Services
      - Instruments
    - Norway Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic
      - Industrial
      - Research
    - Norway End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnological companies
      - Academic research
      - Contract research organizations
      - Others
- Asia Pacific
  - Asia Pacific Expression Systems Outlook (Revenue, USD Million, 2018 - 2030)
    - Prokaryotic
    - Mammalian cell
    - Insect cell
    - Yeast
    - Others
  - Asia Pacific Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Reagents
    - Competent cells
    - Expression vectors
    - Services
    - Instruments
  - Asia Pacific Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Therapeutic
    - Industrial
    - Research
  - Asia Pacific End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Pharmaceutical and biotechnological companies
    - Academic research
    - Contract research organizations
    - Others
  - Japan
    - Japan Expression Systems Outlook (Revenue, USD Million, 2018 - 2030)
      - Prokaryotic
      - Mammalian cell
      - Insect cell
      - Yeast
      - Others
    - Japan Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents
      - Competent cells
      - Expression vectors
      - Services
      - Instruments
    - Japan Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic
      - Industrial
      - Research
    - Japan End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnological companies
      - Academic research
      - Contract research organizations
      - Others
  - China
    - China Expression Systems Outlook (Revenue, USD Million, 2018 - 2030)
      - Prokaryotic
      - Mammalian cell
      - Insect cell
      - Yeast
      - Others
    - China Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents
      - Competent cells
      - Expression vectors
      - Services
      - Instruments
    - China Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic
      - Industrial
      - Research
    - China. End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnological companies
      - Academic research
      - Contract research organizations
      - Others
  - India
    - India Expression Systems Outlook (Revenue, USD Million, 2018 - 2030)
      - Prokaryotic
      - Mammalian cell
      - Insect cell
      - Yeast
      - Others
    - India Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents
      - Competent cells
      - Expression vectors
      - Services
      - Instruments
    - India Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic
      - Industrial
      - Research
    - India End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnological companies
      - Academic research
      - Contract research organizations
      - Others
  - Australia
    - Australia Expression Systems Outlook (Revenue, USD Million, 2018 - 2030)
      - Prokaryotic
      - Mammalian cell
      - Insect cell
      - Yeast
      - Others
    - Australia Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents
      - Competent cells
      - Expression vectors
      - Services
      - Instruments
    - Australia Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic
      - Industrial
      - Research
    - Australia. End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnological companies
      - Academic research
      - Contract research organizations
      - Others
  - South Korea
    - South Korea Expression Systems Outlook (Revenue, USD Million, 2018 - 2030)
      - Prokaryotic
      - Mammalian cell
      - Insect cell
      - Yeast
      - Others
    - South Korea Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents
      - Competent cells
      - Expression vectors
      - Services
      - Instruments
    - South Korea Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic
      - Industrial
      - Research
    - South Korea End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnological companies
      - Academic research
      - Contract research organizations
      - Others
  - Thailand
    - Thailand Expression Systems Outlook (Revenue, USD Million, 2018 - 2030)
      - Prokaryotic
      - Mammalian cell
      - Insect cell
      - Yeast
      - Others
    - Thailand Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents
      - Competent cells
      - Expression vectors
      - Services
      - Instruments
    - Thailand Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic
      - Industrial
      - Research
    - Thailand End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnological companies
      - Academic research
      - Contract research organizations
      - Others
- Latin America
  - Latin America Expression Systems Outlook (Revenue, USD Million, 2018 - 2030)
    - Prokaryotic
    - Mammalian cell
    - Insect cell
    - Yeast
    - Others
  - Latin America Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Reagents
    - Competent cells
    - Expression vectors
    - Services
    - Instruments
  - Latin America Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Therapeutic
    - Industrial
    - Research
  - Latin America End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Pharmaceutical and biotechnological companies
    - Academic research
    - Contract research organizations
    - Others
  - Brazil
    - Brazil Expression Systems Outlook (Revenue, USD Million, 2018 - 2030)
      - Prokaryotic
      - Mammalian cell
      - Insect cell
      - Yeast
      - Others
    - Brazil Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents
      - Competent cells
      - Expression vectors
      - Services
      - Instruments
    - Brazil Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic
      - Industrial
      - Research
    - Brazil End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnological companies
      - Academic research
      - Contract research organizations
      - Others
  - Argentina
    - Argentina Expression Systems Outlook (Revenue, USD Million, 2018 - 2030)
      - Prokaryotic
      - Mammalian cell
      - Insect cell
      - Yeast
      - Others
    - Argentina Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents
      - Competent cells
      - Expression vectors
      - Services
      - Instruments
    - Argentina application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic
      - Industrial
      - Research
    - Argentina End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnological companies
      - Academic research
      - Contract research organizations
      - Others
- MEA
  - MEA Expression Systems Outlook (Revenue, USD Million, 2018 - 2030)
    - Prokaryotic
    - Mammalian cell
    - Insect cell
    - Yeast
    - Others
  - MEA Product Outlook (Revenue, USD Million, 2018 - 2030)
    - Reagents
    - Competent cells
    - Expression vectors
    - Services
    - Instruments
  - MEA Application Outlook (Revenue, USD Million, 2018 - 2030)
    - Therapeutic
    - Industrial
    - Research
  - MEA End Use Outlook (Revenue, USD Million, 2018 - 2030)
    - Pharmaceutical and biotechnological companies
    - Academic research
    - Contract research organizations
    - Others
  - South Africa
    - South Africa Expression Systems Outlook (Revenue, USD Million, 2018 - 2030)
      - Prokaryotic
      - Mammalian cell
      - Insect cell
      - Yeast
      - Others
    - South Africa Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents
      - Competent cells
      - Expression vectors
      - Services
      - Instruments
    - South Africa Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic
      - Industrial
      - Research
    - South Africa End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnological companies
      - Academic research
      - Contract research organizations
      - Others
  - Saudi Arabia
    - Saudi Arabia Expression Systems Outlook (Revenue, USD Million, 2018 - 2030)
      - Prokaryotic
      - Mammalian cell
      - Insect cell
      - Yeast
      - Others
    - Saudi Arabia Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents
      - Competent cells
      - Expression vectors
      - Services
      - Instruments
    - Saudi Arabia Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic
      - Industrial
      - Research
    - Saudi Arabia End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnological companies
      - Academic research
      - Contract research organizations
      - Others
  - UAE
    - UAE Expression Systems Outlook (Revenue, USD Million, 2018 - 2030)
      - Prokaryotic
      - Mammalian cell
      - Insect cell
      - Yeast
      - Others
    - UAE Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents
      - Competent cells
      - Expression vectors
      - Services
      - Instruments
    - UAE Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic
      - Industrial
      - Research
    - UAE End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnological companies
      - Academic research
      - Contract research organizations
      - Others
  - Kuwait
    - Kuwait Expression Systems Outlook (Revenue, USD Million, 2018 - 2030)
      - Prokaryotic
      - Mammalian cell
      - Insect cell
      - Yeast
      - Others
    - Kuwait Product Outlook (Revenue, USD Million, 2018 - 2030)
      - Reagents
      - Competent cells
      - Expression vectors
      - Services
      - Instruments
    - Kuwait Application Outlook (Revenue, USD Million, 2018 - 2030)
      - Therapeutic
      - Industrial
      - Research
    - Kuwait End Use Outlook (Revenue, USD Million, 2018 - 2030)
      - Pharmaceutical and biotechnological companies
      - Academic research
      - Contract research organizations
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments